Evaluation of lung tumor response to therapy: Current and emerging techniques - 14/10/16
Abstract |
Lung tumor response to therapy may be evaluated in most instances by morphological criteria such as RECIST 1.1 on computed tomography (CT) or magnetic resonance imaging (MRI). However, those criteria are limited because they are based on tumoral dimensional changes and do not take into account other morphologic criteria such as density evaluation, functional or metabolic changes that may occur following conventional or targeted chemotherapy. New techniques such as dual-energy CT, PET-CT, MRI including diffusion-weighted MRI has to be considered into the new technical armamentarium for tumor response evaluation. Integration of all informations provided by the different imaging modalities has to be integrated and represents probably the future goal of tumor response evaluation. The aim of the present paper is to review the current and emerging imaging criteria used to evaluate the response of therapy in the field of lung cancer.
Le texte complet de cet article est disponible en PDF.Keywords : Lung tumor, RECIST, Computed tomography, Perfusion, PET-CT
Plan
Vol 97 - N° 10
P. 1053-1065 - octobre 2016 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.